<?xml version="1.0" encoding="UTF-8"?>
<ref id="B92-vaccines-07-00045">
 <label>92.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sok</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Laserson</surname>
    <given-names>U.</given-names>
   </name>
   <name>
    <surname>Laserson</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Vigneault</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Julien</surname>
    <given-names>J.P.</given-names>
   </name>
   <name>
    <surname>Briney</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Ramos</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Saye</surname>
    <given-names>K.F.</given-names>
   </name>
   <name>
    <surname>Le</surname>
    <given-names>K.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies</article-title>
  <source>PLoS Pathog.</source>
  <year>2013</year>
  <volume>9</volume>
  <elocation-id>e1003754</elocation-id>
  <pub-id pub-id-type="doi">10.1371/annotation/f1f8c791-61e9-45c6-a455-92c6dadf9f06</pub-id>
  <pub-id pub-id-type="pmid">24278016</pub-id>
 </element-citation>
</ref>
